Arch Biopartners Inc (ACHFF)
1.29
-0.01
(-0.77%)
USD |
OTCM |
May 03, 16:00
Arch Biopartners Max Drawdown (5Y): 80.88% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 80.88% |
March 31, 2024 | 80.88% |
February 29, 2024 | 80.88% |
January 31, 2024 | 80.88% |
December 31, 2023 | 80.88% |
November 30, 2023 | 80.88% |
October 31, 2023 | 80.25% |
September 30, 2023 | 78.64% |
August 31, 2023 | 69.17% |
July 31, 2023 | 63.87% |
June 30, 2023 | 63.87% |
May 31, 2023 | 63.87% |
April 30, 2023 | 61.07% |
March 31, 2023 | 61.07% |
February 28, 2023 | 61.07% |
January 31, 2023 | 61.07% |
December 31, 2022 | 61.07% |
November 30, 2022 | 61.07% |
October 31, 2022 | 61.07% |
September 30, 2022 | 61.07% |
August 31, 2022 | 61.07% |
July 31, 2022 | 61.07% |
June 30, 2022 | 61.07% |
May 31, 2022 | 61.07% |
April 30, 2022 | 61.07% |
Date | Value |
---|---|
March 31, 2022 | 61.07% |
February 28, 2022 | 61.07% |
January 31, 2022 | 61.07% |
December 31, 2021 | 61.07% |
November 30, 2021 | 61.07% |
October 31, 2021 | 61.07% |
September 30, 2021 | 61.07% |
August 31, 2021 | 61.07% |
July 31, 2021 | 61.07% |
June 30, 2021 | 61.07% |
May 31, 2021 | 61.07% |
April 30, 2021 | 61.07% |
March 31, 2021 | 61.07% |
February 28, 2021 | 61.07% |
January 31, 2021 | 61.07% |
December 31, 2020 | 65.11% |
November 30, 2020 | 65.11% |
October 31, 2020 | 72.19% |
September 30, 2020 | 73.01% |
August 31, 2020 | 73.01% |
July 31, 2020 | 73.01% |
June 30, 2020 | 73.01% |
May 31, 2020 | 73.01% |
April 30, 2020 | 73.01% |
March 31, 2020 | 73.01% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
61.07%
Minimum
Jan 2021
81.29%
Maximum
May 2019
68.17%
Average
63.87%
Median
May 2023
Max Drawdown (5Y) Benchmarks
Acasti Pharma Inc | 98.73% |
Aurinia Pharmaceuticals Inc | 87.58% |
Edesa Biotech Inc | 99.58% |
Lexaria Bioscience Corp | 98.90% |
Xenon Pharmaceuticals Inc | 64.74% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -12.34 |
Beta (5Y) | 1.392 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 67.23% |
Historical Sharpe Ratio (5Y) | 0.0472 |
Historical Sortino (5Y) | 0.1231 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 22.04% |